摘要:
Provided herein are novel polymorphic forms and co-crystals of a compound useful in the treatment, prevention, or amelioration of cancer. In particular, the invention provides polymorphs and co-crystals of 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one, which is an inhibitor of c-Met.
摘要:
A process for preserving process cheese which comprises admixing with natural cheese during the steps of preparing process cheese from natural cheese sorbic acid-containing powder or granules having particle diameter of 300 microns or more comprising 5-90% by weight of finely divided sorbic acid and 10-95% by weight of an easily water-soluble substance which is a solid at normal temperature.
摘要:
DESCRIBED IS A PROCESS FOR PREPARING 2-TRANS-4-TRANS SORBIC ACID FROM PURE METHYL 2-CIS-5,2-TRANS-5,3-TRANS-5, HEXADIENOATE OR FORM MIXTURES THEREOF. THE PROCESS IS CHARACTERIZED BY THE FOLLOWING STEPS: METHYL HEXADIENOATE IS DISSOLVED IN METHANOL, USING 0.5 TO 1 PART OF METHANOL PER 1 PART OF ESTER; SOLID SODIUM HYDROXIDE IS ADDED IN AMOUNT FROM 0.5 TO 3% BY WEIGHT IN RESPECT OF THE ESTER AND THE WHOLE IS AGITATED AT 20-40*C. FOR 60-120 MINUTES (STEP A); SODIUM HYDROXIDE IS ADDED IN STOICHIOMETRIC AMOUNT FOR THE SAPONIFICATION AND THE WHOLE IS HEATED TO 60-80*C. FOR 60-120 MINUTES UNDER STIRRING (STEP B); WATER IS ADDED IN AMOUNT FROM 0.5 TO 1.5 VOLUMES OF WATER PER VOLUME OF SOLUTION IN ORDER TO DISSOLVE THE SALTS, AND THE METHANOL IS DISTILLED (STEP C); THE SOLUTION IS ACIDIFIED TO PH OF 3.5 WITH 5-15% SULFURIC ACID (STEP D); AFTER FILTRATION AT BETWEEN 30 AND 40*C. (STEP E), THE FILTER CAKE IS WASHED WITH WATER AND WITH AQUEOUS METHANOL (STEP F) THUS OBTAINING 2-TRANS-4-TRANS SORBIC ACID, WITH A PURITY HIGHER THAN 99%.
摘要:
A synthetic nicotine composition comprising synthetic nicotine, a synthetic nicotine salt and a synthetic nicotine derivative, wherein the synthetic nicotine, the synthetic nicotine salt, and the synthetic nicotine derivative are in mass percentage; the synthetic nicotine accounts for 1-20%, the synthetic nicotine salt accounts for 30-70%, and the synthetic nicotine derivative accounts for 20-50%; and the synthetic nicotine is one or more of S-nicotine and a mixture of R-nicotine containing a racemate and S-nicotine. The synthetic nicotine, synthetic nicotine salt and synthetic nicotine derivative according to the present invention are proportionally mixed to prepare an existing synthetic nicotine product, which relieves the problem of the impact of impurities in natural extracted nicotine products causing an unpleasant smell, a bitter taste and a strong volatility, and can be used in the fields of low temperature heat-not-burn products, snuff, electronic cigarettes, nicotine release patches, insecticides, herbicides, microbicides, drug synthesis, etc.
摘要:
The present disclosure provides co-crystals of a lithium benzoate compound and a co-former compound of Formula (I) Also provided herein are methods of preparing the co-crystals and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, bipolar disorders, or neurodegenerative disorders).
摘要:
The present invention discloses a method of producing potassium sorbate particles, comprising the steps of: (1) preparing a potassium sorbate solution; (2) spray drying; (3) spray forming; (4) indirectly drying with steam on a vibration fluidized bed; and (5) swing-type sifting; in step (3), a binder is obtained by spray drying after adding sorbitol to the potassium sorbate solution prepared in step (1), and the binder is mixed with the potassium sorbate powder obtained by spray drying in step (2) to undergo the spray forming process; based on weight ratio, the weight ratio of the sorbitol required to prepare the binder to the potassium sorbate solution required to prepare the binder is 0.05-0.1%:1. The beneficial effects of the present invention are: an appropriate binding effect of the powder particles, a good breaking effect and a good spheronization effect of the powder particles, and uniformity of granulation.
摘要:
Described is a method of making sorbic acid, pentadiene, or 3-penten-2-one. The method includes partially hydrogenating 4-hydroxy-6-methyl-2-pyrone (HMP) to yield 5,6-dihydro-4-hydroxy-6-methyl-2H-pyran-2-one (4-DHMMP). Then, if 3-penten-2-one is desired, thermally decomposing the 4-DHMMP to yield 3-penten-2-one. If sorbic acid or pentadiene are desired, the 4-DHMMP is hydrogenated to yield 4-hydroxy-6-methyltetrahydro-2-pyrone (4-HMTHP). The 4-HMTHP is then dehydrated by contacting it with a solid acid catalyst to yield parasorbic acid (PSA). The PSA can then be ring-opened by contacting it with a solid acid catalyst. The reaction conditions of the ring-opening reaction can be controlled to yield sorbic acid and/or pentadiene.
摘要:
The present invention relates to a pharmaceutical co-crystal comprising an active pharmaceutical ingredient and a co-crystal agent having the structure R1—C(═O)XH.
摘要:
A process for producing sorbic acid from a polyester obtained by reaction of crotonaldehyde with ketene using an organic acid zinc salt as catalyst is provided, which process comprises dissolving the polyester in an aromatic hydrocarbon solvent having an azeotropic temperature of the solvent with water of 92.degree. to 100.degree. C., followed by washing the polyester solution with water or a mineral acid water to remove zinc matter and continuously contacting the solution with a strongly acidic porous ion exchange resin, the process being simple, commercially profitable, making possible a long term operation of the polyester decomposition apparatus, capable of easily purifying sorbic acid and affording sorbic acid with a good yeild.
摘要:
Esters of carboxylic acids of the formula RCH.sub.2 COOR"' and R'CH:C(R")COOR"' are reacted to form a carboxylic acid and an aliphatic alcohol R"'OH wherein R, R', and R" are individually selected from the group consisting of --H, alkyl moieties of from 1 to 18 carbon atoms and aralkyl moieties, cycloalkyl moieties and alkylaryl moieties of 3 to 18 carbon atoms and R"' is an alkyl moiety of 1 to 18 carbon atoms in the presence of an AMS-1B borosilicate crystalline molecular sieve catalyst under reaction conditions.